M. Daëron and R. Lesourne, Negative signaling in Fc receptor complexes Advances in immunology, pp.39-86, 2006.

H. Turner, J. Kinet, F. Qiu, P. Ray, K. Brown et al., Signalling through the high-affinity IgE receptor Fc epsilonRI Primary structure of c-kit: relationship with the CSF-1/PDGF receptor tyrosine kinase family?oncogenic activation of v-kit involves the deletion of extracellular domain and C terminus, EMBO J, vol.7, pp.1003-1013, 1988.

K. Salim, M. Bottomley, E. Querfurth, M. Zvelebil, I. Gout et al., Distinct specificity in the recognition of phosphoinositides by the pleckstrin homology domains of dynamin and Bruton's tyrosine kinase, EMBO J, vol.15, pp.6241-50, 1996.

R. Jr and R. , Signaling by Kit protein-tyrosine kinase?the stem cell factor receptor, Biochem Biophys Res Commun, vol.337, pp.1-13, 2005.

A. Orfao, A. Garcia-montero, L. Sanchez, and L. Escribano, Recent advances in the understanding of mastocytosis: the role of KIT mutations, British Journal of Haematology, vol.30, issue.1, pp.12-30, 2007.
DOI : 10.1073/pnas.97.14.7732

P. Dubreuil, R. Rottapel, A. Reith, L. Forrester, and A. Bernstein, The Mouse W/c-kit Locus., Annals of the New York Academy of Sciences, vol.599, issue.1 Cell Lineages, pp.58-65, 1990.
DOI : 10.1111/j.1749-6632.1990.tb42364.x

Y. Kitamura, S. Hirota, E. Morii, and T. Nishida, Gain-of-function Mutations of c-kit in Human Diseases, Mast cells and basophils, pp.21-30, 2000.
DOI : 10.1016/B978-012473335-0/50004-0

S. Hirota, K. Isozaki, Y. Moriyama, K. Hashimoto, T. Nishida et al., Gain-of-Function Mutations of c-kit in Human Gastrointestinal Stromal Tumors, Science, vol.279, issue.5350, pp.577-80, 1998.
DOI : 10.1126/science.279.5350.577

D. Metcalfe, Mast cells and mastocytosis, Blood, vol.112, issue.4, pp.946-56, 2008.
DOI : 10.1182/blood-2007-11-078097

M. Ogawa, Y. Matsuzaki, S. Nishikawa, S. Hayashi, T. Kunisada et al., Expression and function of c-kit in hemopoietic progenitor cells, Journal of Experimental Medicine, vol.174, issue.1, pp.63-71, 1991.
DOI : 10.1084/jem.174.1.63

O. Malbec, W. Fridman, and M. Daëron, Negative regulation of c-kit-mediated cell proliferation by FcRIIB, J Immunol, vol.162, pp.4424-4433, 1999.

O. Malbec, C. Schmitt, P. Bruhns, G. Krystal, W. Fridman et al., Src Homology 2 Domain-containing Inositol 5-Phosphatase 1 Mediates Cell Cycle Arrest by Fc??RIIB, Journal of Biological Chemistry, vol.276, issue.32, pp.30381-91, 2001.
DOI : 10.1074/jbc.M011094200

I. Isnardi, P. Bruhns, G. Bismuth, W. Fridman, and M. Daeron, The SH2 domain-containing inositol 5-phosphatase SHIP1 is recruited to the intracytoplasmic domain of human Fc??RIIB and is mandatory for negative regulation of B cell activation, Immunology Letters, vol.104, issue.1-2, pp.156-65, 2006.
DOI : 10.1016/j.imlet.2005.11.027

D. Sepulveda, P. Okkenhaug, K. , L. Rose, J. Hawley et al., Socs1 binds to multiple signalling proteins and suppresses Steel factor-dependent proliferation, The EMBO Journal, vol.18, issue.4, pp.904-919, 1999.
DOI : 10.1093/emboj/18.4.904

N. Casteran, N. Beslu, E. Lecocq, S. Gomez, and P. Dubreuil, Specific and common activities of the FLT3 and KIT tyrosine kinase receptors revealed by the use of cultured mast cells, Leukemia, vol.12, issue.7, pp.1089-98, 1998.
DOI : 10.1038/sj.leu.2401057

O. Malbec, D. Fong, M. Turner, V. Tybulewicz, J. Cambier et al., FcRI-associated lyn-dependent phosphorylation of FcRIIB during negative regulation of mast cell activation, J Immunol, vol.160, pp.1647-58, 1998.

J. Unkeless, Characterization of a monoclonal antibody directed against mouse macrophage and lymphocyte Fc receptors, Journal of Experimental Medicine, vol.150, issue.3, pp.580-96, 1979.
DOI : 10.1084/jem.150.3.580

M. Ogawa, Y. Matsuzaki, S. Nishikawa, S. Hayashi, T. Kunisada et al., Expression and function of c-kit in hemopoietic progenitor cells, Journal of Experimental Medicine, vol.174, issue.1, pp.63-71, 1991.
DOI : 10.1084/jem.174.1.63

M. Busslinger, Transcriptional Control of Early B Cell Development, Annual Review of Immunology, vol.22, issue.1, pp.55-79, 2004.
DOI : 10.1146/annurev.immunol.22.012703.104807

G. R. Mendoza and H. Metzger, Disparity of IgE binding between normal and tumor mouse mast cells, J Immunol, vol.117, pp.1573-1578, 1976.

K. Furuichi, J. Rivera, and C. Isersky, The receptor for immunoglobulin E on rat basophilic leukemia cells: effect of ligand binding on receptor expression., Proceedings of the National Academy of Sciences, vol.82, issue.5, pp.1522-1525, 1985.
DOI : 10.1073/pnas.82.5.1522

V. Supajatura, Differential responses of mast cell Toll-like receptors 2 and 4 in allergy and innate immunity, Journal of Clinical Investigation, vol.109, issue.10, pp.1351-1359, 2002.
DOI : 10.1172/JCI0214704

T. Hochdorfer, Activation of the PI3K pathway increases TLR-induced TNF-?? and IL-6 but reduces IL-1?? production in mast cells, Cellular Signalling, vol.23, issue.5, p.866, 2011.
DOI : 10.1016/j.cellsig.2011.01.012

K. F. Austen and J. A. Boyce, Mast cell lineage development and phenotypic regulation, Leukemia Research, vol.25, issue.7, pp.511-518, 2001.
DOI : 10.1016/S0145-2126(01)00030-3

S. J. Collington, The Role of the CCL2/CCR2 Axis in Mouse Mast Cell Migration In Vitro and In Vivo, The Journal of Immunology, vol.184, issue.11, pp.6114-6123, 2010.
DOI : 10.4049/jimmunol.0904177

F. Jensen, Estradiol and Progesterone Regulate the Migration of Mast Cells from the Periphery to the Uterus and Induce Their Maturation and Degranulation, PLoS ONE, vol.132, issue.2, p.14409, 2010.
DOI : 10.1371/journal.pone.0014409.s001

M. Cebecauer, J. Cerny, and V. Horejsi, Incorporation of Leucocyte GPI-Anchored Proteins and Protein Tyrosine Kinases into Lipid-Rich Membrane Domains of COS-7 Cells, Biochemical and Biophysical Research Communications, vol.243, issue.3, pp.706-710, 1998.
DOI : 10.1006/bbrc.1998.8149

L. Matsuuchi and M. R. Gold, New views of BCR structure and organization, Current Opinion in Immunology, vol.13, issue.3, pp.270-277, 2001.
DOI : 10.1016/S0952-7915(00)00215-6

M. S. Kuhns, M. M. Davis, and K. C. Garcia, Deconstructing the Form and Function of the TCR/CD3 Complex, Immunity, vol.24, issue.2, pp.133-139, 2006.
DOI : 10.1016/j.immuni.2006.01.006

B. Wang, Epidermal Langerhans cells from normal human skin bind monomeric IgE via Fc epsilon RI, Journal of Experimental Medicine, vol.175, issue.5, pp.1353-1365, 1992.
DOI : 10.1084/jem.175.5.1353

F. Jonsson, Human Fc??RIIA induces anaphylactic and allergic reactions, Blood, vol.119, issue.11, pp.2533-2544, 2012.
DOI : 10.1182/blood-2011-07-367334

M. Dy and E. Schneider, Interleukin-­?3 (IL-­?3) and granulocyte-­?macrophage colony-­? stimulating factor (GM-­?CSF): two cytokines increasing histamine synthesis by hematopoietic cells, Eur Cytokine Netw, vol.2, pp.153-172, 1991.

M. Yanagida, Effects of T-­?helper 2-­?type cytokines, interleukin-­?3 (IL-­?3), IL-­?4, IL-­?5, and IL-­?6 on the survival of cultured human mast cells, Blood, vol.86, pp.3705-3714, 1995.

Y. A. Mekori, C. K. Oh, and D. D. Metcalfe, The Role of c-Kit and Its Ligand, Stem Cell Factor, in Mast Cell Apoptosis, International Archives of Allergy and Immunology, vol.107, issue.1-3, pp.136-138, 1995.
DOI : 10.1159/000236955

I. Willox, I. Mirkina, J. Westwick, and S. G. Ward, Evidence for PI3K-dependent CXCR3 agonist-induced degranulation of human cord blood-derived mast cells, Molecular Immunology, vol.47, issue.14
DOI : 10.1016/j.molimm.2010.05.005

N. Dietrich, Mast cells elicit proinflammatory but not type I interferon responses upon activation of TLRs by bacteria, Proceedings of the National Academy of Sciences, vol.107, issue.19, pp.8748-8753, 2010.
DOI : 10.1073/pnas.0912551107

E. Babolewska, P. Witczak, A. Pietrzak, and E. Brzezinska-­?blaszczyk, Different potency of bacterial antigens, both TLR2 and TLR4 ligands, in stimulating mature mast cells to cysteinyl leukotriene synthesis, Microbiol Immunol, 2012.

A. Pietrzak, M. Wierzbicki, M. Wiktorska, and E. Brzezinska-­?blaszczyk, Surface TLR2 and TLR4 Expression on Mature Rat Mast Cells Can Be Affected by Some Bacterial Components and Proinflammatory Cytokines, Mediators of Inflammation, vol.169, issue.7, p.427473, 2011.
DOI : 10.1159/000232565

L. A. Ducharme and J. H. Weis, Modulation of integrin expression during mast cell differentiation, European Journal of Immunology, vol.173, issue.10, pp.2603-2607, 1992.
DOI : 10.1002/eji.1830221020

M. F. Gurish, Expression of murine beta 7, alpha 4, and beta 1 integrin genes by rodent mast cells, J Immunol, vol.149, pp.1964-1972, 1992.

C. S. Goh, D. Milburn, and M. Gerstein, Conformational changes associated with protein???protein interactions, Current Opinion in Structural Biology, vol.14, issue.1, pp.104-109, 2004.
DOI : 10.1016/j.sbi.2004.01.005

B. F. Volkman, D. Lipson, D. E. Wemmer, and D. Kern, Two-State Allosteric Behavior in a Single-Domain Signaling Protein, Science, vol.291, issue.5512, pp.2429-2433, 2001.
DOI : 10.1126/science.291.5512.2429

G. Maksay, Ligand-­?gated pentameric ion channels, from binding to gating, Curr Mol Pharmacol, vol.2, pp.253-262, 2009.

M. J. Rebecchi and S. Scarlata, PLECKSTRIN HOMOLOGY DOMAINS: A Common Fold with Diverse Functions, Annual Review of Biophysics and Biomolecular Structure, vol.27, issue.1, pp.503-528, 1998.
DOI : 10.1146/annurev.biophys.27.1.503

L. C. Cantley, The Phosphoinositide 3-Kinase Pathway, Science, vol.296, issue.5573, pp.1655-1657, 2002.
DOI : 10.1126/science.296.5573.1655

W. Weissenhorn, M. J. Eck, S. C. Harrison, and D. C. Wiley, Phosphorylated T Cell Receptor zeta-chain and ZAP70 Tandem SH2 Domains form a 1:3 Complex in vitro, European Journal of Biochemistry, vol.255, issue.2
DOI : 10.1016/0092-8674(92)90032-8

E. A. Ottinger, M. C. Botfield, and S. E. Shoelson, Tandem SH2 Domains Confer High Specificity in Tyrosine Kinase Signaling, Journal of Biological Chemistry, vol.273, issue.2, pp.729-735, 1998.
DOI : 10.1074/jbc.273.2.729

R. A. Grucza and S. Saitoh, LAT is essential for Fc(epsilon)RI-­?mediated mast cell activation, Immunity, vol.12, pp.525-535, 2000.

V. Parravicini, Fyn kinase initiates complementary signals required for IgE-dependent mast cell degranulation, Nature Immunology, vol.3, pp.741-748, 2002.
DOI : 10.1038/ni817

P. Wonerow and S. P. Watson, The transmembrane adapter LAT plays a central role in immune receptor signalling, Oncogene, vol.20, issue.44, pp.6273-6283, 2001.
DOI : 10.1038/sj.onc.1204770

K. Roget, M. Malissen, O. Malbec, B. Malissen, and M. Daeron, Non-T Cell Activation Linker Promotes Mast Cell Survival by Dampening the Recruitment of SHIP1 by Linker for Activation of T Cells, The Journal of Immunology, vol.180, issue.6, pp.3689-3698, 2008.
DOI : 10.4049/jimmunol.180.6.3689

URL : https://hal.archives-ouvertes.fr/pasteur-00269365

H. Gu, Essential role for Gab2 in the allergic response, Nature, vol.412, issue.6843, pp.186-190, 2001.
DOI : 10.1038/35084076

K. Ali, Essential role for the p110?? phosphoinositide 3-kinase in the allergic response, Nature, vol.105, issue.7011, pp.1007-1011, 2004.
DOI : 10.1016/S1074-7613(02)00282-0

J. Rivera, Molecular adapters in Fc??RI signaling and the allergic response, Current Opinion in Immunology, vol.14, issue.6, pp.688-693, 2002.
DOI : 10.1016/S0952-7915(02)00396-5

S. Iwaki, C. Tkaczyk, D. D. Metcalfe, and A. M. Gilfillan, Roles of adaptor molecules in mast cell activation, Chem Immunol Allergy, vol.87, pp.43-58, 2005.

T. B. Van-dijk, Stem cell factor induces phosphatidylinositol 3'-­?kinase-­? dependent Lyn/Tec/Dok-­?1 complex formation in hematopoietic cells, Blood, vol.96, pp.3406-3413, 2000.

H. Zhang, PDGFRs are critical for PI3K/Akt activation and negatively regulated by mTOR, Journal of Clinical Investigation, vol.117, issue.3, pp.730-738, 2007.
DOI : 10.1172/JCI28984

N. Z. Trieselmann, J. Soboloff, and S. A. Berger, Mast cells stimulated by membrane-­? bound, but not soluble

J. I. Wilde and S. P. Watson, Regulation of phospholipase C ?? isoforms in haematopoietic cells, Cellular Signalling, vol.13, issue.10, pp.691-701, 2001.
DOI : 10.1016/S0898-6568(01)00191-7

A. B. Pernis and P. B. Rothman, JAK-STAT signaling in asthma, Journal of Clinical Investigation, vol.109, issue.10, pp.1279-1283, 2002.
DOI : 10.1172/JCI0215786

M. Muzio, N. Polentarutti, D. Bosisio, M. Kumar, P. P. Mantovani et al., Toll-like receptor family and signalling pathway, Biochemical Society Transactions, vol.28, issue.5, pp.563-566, 2000.
DOI : 10.1042/bst0280563

M. U. Martin and H. Wesche, Summary and comparison of the signaling mechanisms of the Toll/interleukin-1 receptor family, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, vol.1592, issue.3, pp.265-280, 2002.
DOI : 10.1016/S0167-4889(02)00320-8

S. J. Galli, K. M. Zsebo, and E. N. Geissler, The kit Ligand, Stem Cell Factor, Adv Immunol, vol.55, pp.1-96, 1994.
DOI : 10.1016/S0065-2776(08)60508-8

S. J. Galli, New Insights into ???The Riddle of the Mast Cells???: Microenvironmental Regulation of Mast Cell Development and Phenotypic Heterogeneity, Lab Invest, vol.62, pp.5-33, 1990.
DOI : 10.1007/978-1-4612-0485-5_5

Y. Kitamura, Heterogeneity of Mast Cells and Phenotypic Change Between Subpopulations, Annual Review of Immunology, vol.7, issue.1, pp.59-76, 1989.
DOI : 10.1146/annurev.iy.07.040189.000423

R. Pedotti, Multiple elements of the allergic arm of the immune response modulate autoimmune demyelination, Proceedings of the National Academy of Sciences, vol.100, issue.4, pp.1867-1872, 2003.
DOI : 10.1073/pnas.252777399

D. M. Lee, Mast Cells: A Cellular Link Between Autoantibodies and Inflammatory Arthritis, Science, vol.297, issue.5587, pp.1689-1692, 2002.
DOI : 10.1126/science.1073176

T. B. Feyerabend, Cre-Mediated Cell Ablation Contests Mast Cell Contribution in Models of Antibody- and T Cell-Mediated Autoimmunity, Immunity, vol.35, issue.5, 2011.
DOI : 10.1016/j.immuni.2011.09.015

B. G. Neel, H. Gu, and L. Pao, The ???Shp'ing news: SH2 domain-containing tyrosine phosphatases in cell signaling, Trends in Biochemical Sciences, vol.28, issue.6, pp.284-293, 2003.
DOI : 10.1016/S0968-0004(03)00091-4

K. Backers, D. Blero, N. Paternotte, J. Zhang, and C. Erneux, The termination of PI3K signalling by SHIP1 and SHIP2 inositol 5-phosphatases, Advances in Enzyme Regulation, vol.43, issue.1, pp.15-28, 2003.
DOI : 10.1016/S0065-2571(02)00043-2

S. E. Gustin, C. B. Thien, and W. Langdon, Cbl-b Is a Negative Regulator of Inflammatory Cytokines Produced by IgE-Activated Mast Cells, The Journal of Immunology, vol.177, issue.9, pp.5980-5989, 2006.
DOI : 10.4049/jimmunol.177.9.5980

L. D. Shultz, D. R. Coman, C. L. Bailey, W. G. Beamer, and C. L. Sidman, Viable motheaten," a new allele at the motheaten locus. I. Pathology, Am J Pathol, vol.116, pp.179-192, 1984.

S. Pfirsch-­?maisonnas, Inhibitory ITAM Signaling Traps Activating Receptors with the Phosphatase SHP-1 to Form Polarized "Inhibisome" Clusters, Science Signaling, vol.4, issue.169, p.24, 2011.
DOI : 10.1126/scisignal.2001309

M. Aloulou, IgG1 and IVIg induce inhibitory ITAM signaling through Fc??RIII controlling inflammatory responses, Blood, vol.119, issue.13, pp.3084-3096, 2012.
DOI : 10.1182/blood-2011-08-376046

C. D. Helgason, Targeted disruption of SHIP leads to hemopoietic perturbations, lung pathology, and a shortened life??span, Genes & Development, vol.12, issue.11, pp.1610-1620, 1998.
DOI : 10.1101/gad.12.11.1610

H. Ohtake, N. Ichikawa, M. Okada, and T. Yamashita, Cutting Edge: Transmembrane Phosphoprotein Csk-Binding Protein/Phosphoprotein Associated With Glycosphingolipid-Enriched Microdomains as a Negative Feedback Regulator of Mast Cell Signaling Through the Fc??RI, The Journal of Immunology, vol.168, issue.5, pp.2087-2090, 2002.
DOI : 10.4049/jimmunol.168.5.2087

S. A. Solheim, Interactions between the Fyn SH3-domain and adaptor protein Cbp/PAG derived ligands, effects on kinase activity and affinity, FEBS Journal, vol.28, issue.19, pp.4863-4874, 2008.
DOI : 10.1111/j.1742-4658.2008.06626.x

Z. Zhu, Tyrosine phosphatase SHP-1 in allergic and anaphylactic inflammation, Immunologic Research, vol.168, issue.1-3, pp.3-13, 2010.
DOI : 10.1007/s12026-009-8134-5

K. Nakata, Positive and Negative Regulation of High Affinity IgE Receptor Signaling by Src Homology Region 2 Domain-Containing Phosphatase 1, The Journal of Immunology, vol.181, issue.8, pp.5414-5424, 2008.
DOI : 10.4049/jimmunol.181.8.5414

J. Rivera and A. Olivera, Src family kinases and lipid mediators in control of allergic inflammation, Immunological Reviews, vol.103, issue.1, pp.255-268, 2007.
DOI : 10.1084/jem.20051982

O. Malbec, Peritoneal Cell-Derived Mast Cells: An In Vitro Model of Mature Serosal-Type Mouse Mast Cells, The Journal of Immunology, vol.178, issue.10, pp.6465-6475, 2007.
DOI : 10.4049/jimmunol.178.10.6465

URL : https://hal.archives-ouvertes.fr/pasteur-00181324

M. Dembo and B. Goldstein, Theory of equilibrium binding of symmetric bivalent haptens to cell surface antibody: application to histamine release from basophils

M. C. Siracusa, J. G. Perrigoue, M. R. Comeau, and D. Artis, New paradigms in basophil development, regulation and function, Immunology and Cell Biology, vol.181, issue.3, pp.275-284, 2010.
DOI : 10.1084/jem.20040598

J. Ruschmann, The Role of SHIP in the Development and Activation of Mouse Mucosal and Connective Tissue Mast Cells, The Journal of Immunology, vol.188, issue.8, 2012.
DOI : 10.4049/jimmunol.1003875

A. Komiya, Expression and Function of Toll-Like Receptors in Human Basophils, International Archives of Allergy and Immunology, vol.140, issue.1, pp.23-27, 2006.
DOI : 10.1159/000092707

P. Valent, Cytokines involved in growth and differentiation of human basophils and mast cells, Experimental Dermatology, vol.84, issue.4, pp.255-259, 1995.
DOI : 10.1084/jem.175.1.237

B. Min, Basophils: what they 'can do' versus what they 'actually do', Nature Immunology, vol.178, issue.12, pp.1333-1339, 2008.
DOI : 10.1128/MCB.00631-07

B. Echtenacher, D. N. Mannel, and L. Hultner, Critical protective role of mast cells in a model of acute septic peritonitis, Nature, vol.381, issue.6577, pp.75-77, 1996.
DOI : 10.1038/381075a0

R. Malaviya and S. N. Abraham, Mast cell modulation of immune responses to bacteria, Immunological Reviews, vol.179, issue.1, pp.16-24, 2001.
DOI : 10.1034/j.1600-065X.2001.790102.x

W. Dawicki and J. Marshall, New and emerging roles for mast cells in host defence, Current Opinion in Immunology, vol.19, issue.1, pp.31-38, 2007.
DOI : 10.1016/j.coi.2006.11.006

S. J. Galli, M. Maurer, and C. S. Lantz, Mast cells as sentinels of innate immunity, Current Opinion in Immunology, vol.11, issue.1, pp.53-59, 1999.
DOI : 10.1016/S0952-7915(99)80010-7

Y. A. Mekori and D. D. Metcalfe, Mast cells in innate immunity, Immunological Reviews, vol.173, issue.1, pp.131-140, 2000.
DOI : 10.1034/j.1600-065X.2000.917305.x

S. J. Galli, S. Nakae, and M. Tsai, Mast cells in the development of adaptive immune responses, Nature Immunology, vol.171, issue.2, pp.135-142, 2005.
DOI : 10.1172/JCI200111494

D. M. Jawdat, E. J. Albert, G. Rowden, I. D. Haidl, and J. S. Marshall, IgE-Mediated Mast Cell Activation Induces Langerhans Cell Migration In Vivo, The Journal of Immunology, vol.173, issue.8, pp.5275-5282, 2004.
DOI : 10.4049/jimmunol.173.8.5275

S. T. Holgate, Pathophysiology of asthma: What has our current understanding taught us about new therapeutic approaches?, Journal of Allergy and Clinical Immunology, vol.128, issue.3, pp.495-505, 2011.
DOI : 10.1016/j.jaci.2011.06.052

R. Valenta, B. Linhart, I. Swoboda, and V. M. Niederberger, Recombinant allergens for allergen-specific immunotherapy: 10???years anniversary of immunotherapy with recombinant allergens, Allergy, vol.122, issue.6, pp.775-783, 2008.
DOI : 10.1111/j.1398-9995.2011.02565.x

B. A. Sayed, A. Christy, M. R. Quirion, and M. A. Brown, The Master Switch: The Role of Mast Cells in Autoimmunity and Tolerance, Annual Review of Immunology, vol.26, issue.1, pp.705-739, 2008.
DOI : 10.1146/annurev.immunol.26.021607.090320

C. Lock, Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis, Nature Medicine, vol.158, issue.5, pp.500-508, 2002.
DOI : 10.1038/ng0896-464

R. Chen, Mast cells play a key role in neutrophil recruitment in experimental bullous pemphigoid, Journal of Clinical Investigation, vol.108, issue.8, pp.1151-1158, 2001.
DOI : 10.1172/JCI11494

K. Hochegger, Role of mast cells in experimental anti-glomerular basement membrane glomerulonephritis, European Journal of Immunology, vol.77, issue.10, pp.3074-3082, 2005.
DOI : 10.1002/eji.200526250

M. Robbie-­?ryan, M. B. Tanzola, V. H. Secor, and M. A. Brown, Cutting Edge: Both Activating and Inhibitory Fc Receptors Expressed on Mast Cells Regulate Experimental Allergic Encephalomyelitis Disease Severity, The Journal of Immunology, vol.170, issue.4, pp.1630-1634, 2003.
DOI : 10.4049/jimmunol.170.4.1630

S. Pillai, H. Mattoo, A. Cariappa, H. P. Sotlar, K. Valent et al., B cells and autoimmunity, Current Opinion in Immunology, vol.23, issue.6, pp.721-731, 2007.
DOI : 10.1016/j.coi.2011.10.007

F. C. Eberle, H. Mani, and E. S. Jaffe, Histopathology of Hodgkin???s Lymphoma, The Cancer Journal, vol.15, issue.2, pp.129-137, 2009.
DOI : 10.1097/PPO.0b013e31819e31cf

J. G. Gribben, Implications of the tumor microenvironment on survival and disease response in follicular lymphoma, Current Opinion in Oncology, vol.22, issue.5, pp.424-430, 2010.
DOI : 10.1097/CCO.0b013e32833d5938

H. Nogai, B. Dorken, and G. Lenz, Pathogenesis of Non-Hodgkin's Lymphoma, Journal of Clinical Oncology, vol.29, issue.14, pp.1803-1811, 2011.
DOI : 10.1200/JCO.2010.33.3252

E. Campo, The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications, Blood, vol.117, issue.19, pp.5019-5032, 2008.
DOI : 10.1182/blood-2011-01-293050

S. Camilleri-­?broet, FcgammaRIIB is differentially expressed during B cell maturation and in B-cell lymphomas, British Journal of Haematology, vol.85, issue.1, pp.55-62, 2004.
DOI : 10.1002/(SICI)1097-0215(19961009)68:2<219::AID-IJC14>3.0.CO;2-5

R. Matre, O. Tonder, and C. Endresen, Fc Receptors in Human Placenta, Scandinavian Journal of Immunology, vol.10, issue.6, pp.741-745, 1975.
DOI : 10.1084/jem.119.2.265

L. A. Hussain, The expression of Fc receptors for immunoglobulin G in human rectal epithelium, AIDS, vol.5, issue.9, pp.1089-1094, 1991.
DOI : 10.1097/00002030-199109000-00004

V. Estienne, Androgen-dependent expression of FcgammaRIIB2 by thyrocytes from patients with autoimmune Graves' disease: a possible molecular clue for sex dependence of autoimmune disease, The FASEB Journal, vol.16, issue.9, pp.1087-1092, 2002.
DOI : 10.1096/fj.01-0998hyp

H. W. Noltenius, Fc and complement receptors on malignant tumor cells, Cancer, vol.114, issue.8, pp.1761-1767, 1981.
DOI : 10.1002/1097-0142(19811015)48:8<1761::AID-CNCR2820480812>3.0.CO;2-C

L. Cassard, Selective expression of inhibitory Fc?? receptor by metastatic melanoma impairs tumor susceptibility to IgG-dependent cellular response, International Journal of Cancer, vol.4, issue.12, pp.2832-2839, 2008.
DOI : 10.1002/ijc.23870